![]() |
Volumn 25, Issue 8, 2005, Pages 635-636
|
Severe, refractory type II essential mixed cryoglobulinemia treated with 2-chlorodeoxyadenosine and mycophenolate mofetil
|
Author keywords
2 Chlorodeoxyadenosine; Birmingham vasculitis activity score; Essential mixed cryoglobulinemia; Mycophenolate mofetil
|
Indexed keywords
ALEMTUZUMAB;
CLADRIBINE;
DAPSONE;
DEXAMETHASONE;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISONE;
RITUXIMAB;
VALACICLOVIR;
VORICONAZOLE;
ADULT;
ANAMNESIS;
ARTICLE;
CASE REPORT;
CLINICAL FEATURE;
COMPUTER ASSISTED TOMOGRAPHY;
CRYOGLOBULINEMIA;
DISEASE COURSE;
DISEASE SEVERITY;
ECHOCARDIOGRAPHY;
HUMAN;
HUMAN TISSUE;
KIDNEY FAILURE;
LABORATORY TEST;
MALE;
PLASMAPHERESIS;
PRIORITY JOURNAL;
SKIN BIOPSY;
CLADRIBINE;
CRYOGLOBULINEMIA;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
MIDDLE AGED;
MYCOPHENOLIC ACID;
TREATMENT OUTCOME;
|
EID: 26244456165
PISSN: 01728172
EISSN: None
Source Type: Journal
DOI: 10.1007/s00296-004-0577-3 Document Type: Article |
Times cited : (7)
|
References (7)
|